直肠非甾体类抗炎药对ERCP术后胰腺炎的预防作用

目的观察直肠非甾体类抗炎药（NSAIDs）对ERCP术后高淀粉酶血症及胰腺炎的预防及治疗作用。方法将符合标准的患者随机分为2组,每组30例。预防组在ERCP术前30min肌注地西泮及山莨菪碱各10mg,同时给予引哚美辛栓100mg塞肛;对照组在ERCP术前30min肌注地西泮及山莨菪碱各10mg。ERCP术前及术后6h、24h测定血清淀粉酶水平。结果比较预防组和对照组ERCP术后6h、24h血清淀粉酶的活性,发现ERCP术后6h两组间血清淀粉酶分别为（367．5±268．7）U／L、（1034．2±713．5）U／L,术后24h两组间血清淀粉酶分别为（324．9±142．3）U／L、（826．8±395．7）U／L,两组问差异均有统计学意义（P〈0．05）。结论直肠NSAIDs具有预防ERCP术后高淀粉酶血症及胰腺炎的作用。

Preventive effect of rectal nonsteroidal anti-inflammatory drugs for post-ERCP pancreatitis

Objective To investigate the preventive and therapeutic effects of nonsteroidal anti-inflammatory drugs ( NSAIDs) via rectum for hyperamylasemia and pancreatitis after ERCP (endoscopic retrograde cholangiopancreatography).Methods Sixty patients who underwent ERCP for various reasons were randomly divided into preventive and control groups.In addition to routine diazepam (10 mg) and anisodamine (10 mg) given intramuscularly in both groups before ERCP, 100 mg of indometacin suppositories was administered by rectum in preventive group.Serum amylase level was measured before and 6 hours and 24 hours after the procedure.Results Serum amylase levels at 6 hours after ERCP in preventive and control groups were (367.5 ± 268.7 ) U/L and (1034.2 ± 713.5 ) U/L, respectively ( P < 0.05 ), which were (324.9±142.3)U/L and (826.8 ±395.7)U/L, respectively, at 24 hours after ERCP (P<0.05).Conclusion Rectal use of NSAIDs can prevent hyperamylasemia and acute pancreatitis induced by ERCP.